门冬氨酸钾

Records for this ingredient, by country (identity only).

ATC A12BA · 1 markets · 23 records

门冬氨酸钾 1 markets · 23 records Forms
Filters
MarketCN 23

CN 23 records · 5 shown of 5 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 10 mL per mL / per unit basis not statedinjectionManufacturer: 内蒙古白医制药股份有限公司 ×4Manufacturer: 吉林四长制药有限公司、Manufacturer: 山东华鲁制药有限公司、Manufacturer: 洋浦京泰药业有限公司、Manufacturer: 焦作市民康药业有限公司、Manufacturer: 苏州特瑞药业股份有限公司、Manufacturer: 通辽市华邦药业有限公司
  • 20 mL per mL / per unit basis not statedinjectionManufacturer: 内蒙古白医制药股份有限公司 ×4Manufacturer: 焦作市民康药业有限公司
  • 300 mgtabletManufacturer: 辽宁药联制药有限公司 ×5
  • 3,424 mg/20 mLinjectionManufacturer: 辽宁药联制药有限公司 ×5
  • 1,712 mg/10 mLinjectionManufacturer: 辽宁药联制药有限公司 ×5

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.